ICI-174864
ICI-174864
ICI-174864 is a selective antagonist of the 5-HT2 receptor, specifically targeting the 5-HT2A and 5-HT2C subtypes. It is a compound of interest in the field of neuropharmacology due to its potential applications in research and therapeutic contexts.
Chemical Structure and Properties[edit]
ICI-174864 is a chemical compound with the molecular formula C19H22N2O2. It is characterized by its selective binding affinity to the 5-HT2A and 5-HT2C receptors, which are subtypes of the serotonin receptor family. These receptors are G protein-coupled receptors (GPCRs) that play a crucial role in the modulation of neurotransmission in the central nervous system.
Mechanism of Action[edit]
As a selective antagonist, ICI-174864 binds to the 5-HT2A and 5-HT2C receptors, inhibiting the action of serotonin (5-HT) at these sites. This blockade can modulate various physiological and psychological processes, including mood, perception, and cognition. The selective antagonism of these receptors makes ICI-174864 a valuable tool in research for understanding the role of serotonin in the brain.
Research Applications[edit]
ICI-174864 is primarily used in preclinical research to study the function of 5-HT2 receptors. It has been employed in experiments to:
- Investigate the role of 5-HT2 receptors in psychiatric disorders such as schizophrenia, depression, and anxiety disorders.
- Explore the effects of serotonin on cognition and perception.
- Examine the potential therapeutic effects of 5-HT2 receptor modulation in various neurological disorders.
Therapeutic Potential[edit]
While ICI-174864 itself is not used as a therapeutic agent, its role as a research tool helps in the development of new drugs targeting the 5-HT2 receptors. Understanding the interaction between serotonin and these receptors can lead to the development of novel treatments for mental health disorders.
Safety and Toxicology[edit]
As with many research chemicals, the safety profile of ICI-174864 is not fully established for human use. It is primarily used in controlled laboratory settings, and its effects in humans are not well-documented.
Also see[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
